News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PediaMed Pharmaceuticals, Inc. Acquires Protein Therapeutics; Transaction Focused On Phase II Drug For Autistic Children Who Suffer From Gastrointestinal Dysfunction


10/19/2005 5:10:19 PM

The Pediatrics Company(TM) today announced that it has acquired Protein Therapeutics, a company dedicated to the discovery and development of new therapies for immunological diseases. The acquisition includes an investigational immunoglobulin drug that is entering Phase II clinical trials for gastrointestinal dysfunction in autistic children.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES